The mutIDH1R132H glioma cells were sensitive to inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the NAD+ salvage pathway, which left the mutIDH1R132H cells with few options to increase intracellular NAD+.111. The gene discussed is NAMPT; the disease is glioma.